This article compares oral and injectable GLP-1 treatments in terms of effectiveness, side effects, convenience, and cost, and examines new therapies in the pipeline expected to shape access in 2025 and beyond
These findings have important clinical implications, as they suggest that GLP-1 analogs could be a viable treatment option for patients with MSH, PSW, or other forms of obesity resulting from MC4R deficiencies
This issue warrants a critical examination of the adequacy of current fasting guidelines, particularly for patients taking these medications
[46] Kraemer WJ, Volek JS, French DN, Rubin MR, Sharman MJ, Gmez AL, Ratamess NA, Newton RU, Jemiolo B, Craig BW, Hkkinen K.J Strength Cond Res
Are there any food restrictions while using this injection
On the other hand, high levels of IGF-1 have been associated with an increased risk for developing some types of cancer and even decreased life span